Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body's main tools for slowing or stopping viral infections, yet research led by the universities of Cambridge and Glasgow shows that avian flu strains can keep multiplying even when the body reaches temperatures that normally hinder viruses.
In a study published in Science, the researchers identified a gene that strongly influences how sensitive a flu virus is to heat. During the major pandemics of 1957 and 1968, this gene moved into human flu viruses, and the resulting strains were able to spread efficiently.
Why Temperature Matters for Flu Viruses
Human flu viruses infect millions of people annually, with influenza A being the most common seasonal strain. These viruses replicate most effectively in the upper respiratory tract, where temperatures are around 33 °C. They replicate less efficiently deeper in the lungs, where temperatures rise to about 37 °C.
If left uncontrolled, viruses spread through the body and may cause severe illness. Fever is one of the body's protective responses and can raise core temperature to as high as 41 °C. Until recently, however, it remained unclear exactly how fever limits viral growth, or why some viruses can continue thriving despite it.
Avian Flu Thrives in Hotter Environments
Avian influenza viruses behave differently from human flu strains. They often grow in the lower respiratory tract, and in their usual hosts, including ducks and seagulls, they frequently infect the gut. These environments can reach temperatures of 40 to 42 °C.
Past laboratory studies using cultured cells showed that avian flu viruses tend to withstand temperatures similar to those seen during fever in humans. The new research turns to in vivo models, using mice infected with influenza viruses, to better understand how fever protects the body and why this protection may not be enough against bird flu.
Simulating Fever in Mice
The international team led by scientists in Cambridge and Glasgow created fever-like conditions in mice to observe how different flu strains responded. Their experiments used a laboratory-adapted human-origin influenza virus known as PR8, which is not a danger to humans.
Mice do not usually develop fever in response to influenza A viruses, so the team mimicked fever by raising the temperature of the environment where the mice lived (elevating the body temperature of the mice).
Human Flu Stops at High Heat, Avian Flu Does Not
The findings showed that increasing body temperature to fever levels effectively stopped human-origin flu viruses from replicating. This same temperature increase did not stop avian flu viruses. For human flu strains, raising the temperature by just 2 °C was enough to turn what would have been a lethal infection into a mild one.
A Key Gene Behind Bird Flu's Heat Resistance
The study also found that the PB1 gene, which supports viral genome replication inside infected cells, plays a major role in determining temperature sensitivity. Viruses with an avian-like PB1 gene tolerated fever-associated temperatures and caused severe illness in mice. This matters because human and bird flu viruses can exchange genes when they infect the same host, such as pigs, at the same time.
Dr. Matt Turnbull, first author of the study from the Medical Research Council Centre for Virus Research at the University of Glasgow, said: "The ability of viruses to swap genes is a continued source of threat for emerging flu viruses. We've seen it happen before during previous pandemics, such as in 1957 and 1968, where a human virus swapped its PB1 gene with that from an avian strain. This may help explain why these pandemics caused serious illness in people.
"It's crucial that we monitor bird flu strains to help us prepare for potential outbreaks. Testing potential spillover viruses for how resistant they are likely to be to fever may help us identify more virulent strains."
High Fatality Rates Highlight the Danger
Senior author Professor Sam Wilson, from the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge, said: "Thankfully, humans don't tend to get infected by bird flu viruses very frequently, but we still see dozens of human cases a year. Bird flu fatality rates in humans have traditionally been worryingly high, such as in historic H5N1 infections that caused more than 40% mortality.
"Understanding what makes bird flu viruses cause serious illness in humans is crucial for surveillance and pandemic preparedness efforts. This is especially important because of the pandemic threat posed by avian H5N1 viruses."
Implications for Treatment
Reference: "Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals" by Matthew L. Turnbull, Yingxue Wang, Simon Clare, Gauthier Lieber, Stephanie L. Williams, Marko Noerenberg, Akira J. T. Alexander, Sara Clohisey Hendry, Douglas G. Stewart, Joseph Hughes, Simon Swingler, Spyros Lytras, Emma L. Davies, Katherine Harcourt, Katherine Smollett, Rute M. Pinto, Hui-Min Lee, Eleanor R. Gaunt, Colin Loney, Johanna S. Jung, Paul A. Lyons, Darrell R. Kapczynski, Edward Hutchinson, Ana da Silva Filipe, Jeffery K. Taubenberger, Suzannah J. Rihn, J. Kenneth Baillie, Ervin Fodor, Alfredo Castello, Kenneth G. C. Smith, Paul Digard and Sam J. Wilson, 27 November 2025, Science.
DOI: 10.1126/science.adq4691
The research was funded primarily by the Medical Research Council, with additional funding from the Wellcome Trust, Biotechnology and Biological Sciences Research Council, European Research Council, European Union Horizon 2020, UK Department for Environment, Food & Rural Affairs, and US Department of Agriculture.
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]















